GSK ramps up Shingrix production with $100m investment 25-Apr-2019 By Ben Hargreaves GSK announces that it will spend $100m to expand production capacity for components of Shingrix, amid a US market where demand outstrips supply of its shingles vaccine.
GSK expects ‘limits’ on Shingrix access in 2019 14-Jan-2019 By Ben Hargreaves The company will hold off on advertising and expanding access to new countries until current demand is met.